What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Bovine Respiratory Disease Complex: Bacterial Pathogens and Antimicrobial Resistance Patterns

Abstract

Bovine respiratory disease complex (BRDC) remains the most economically significant infectious disease affecting feedlot cattle globally. The bacterial component of this multifactorial syndrome is primarily driven by four key pathogens: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. These organisms, frequently acting as secondary invaders following viral predisposition or environmental stress, are responsible for the fibrinous and suppurative pneumonias that characterize clinical BRDC. The emergence and dissemination of antimicrobial resistance (AMR) among these bacterial species, particularly against macrolides, tetracyclines, and fluoroquinolones, has compromised traditional metaphylactic and therapeutic protocols. This review provides an exhaustive examination of the bacterial etiologic agents within BRDC, detailing their virulence mechanisms, host-pathogen interactions, and the molecular epidemiology of AMR. Emphasis is placed on the role of integrative and conjugative elements (ICEs) in the horizontal transfer of multidrug resistance, biofilm formation as a contributor to therapeutic failure, and the application of advanced molecular diagnostics for pathogen detection and resistance profiling. Surveillance data from major cattle-producing regions, including North America, Europe, and Asia, are synthesized to document current resistance trends and inform antimicrobial stewardship strategies.

Introduction

Bovine respiratory disease complex is a polymicrobial, multifactorial syndrome arising from the interaction of viral and bacterial pathogens, host susceptibility, and environmental or management-related stressors [1, 2, 3]. It is the leading cause of morbidity and mortality in feedlot cattle, with annual economic losses estimated in the hundreds of millions of dollars in the United States alone due to treatment costs, reduced weight gain, carcass condemnation, and mortality [4, 5, 6]. The pathogenesis of BRDC typically involves a primary viral infection that compromises pulmonary defense mechanisms, followed by colonization of the lower respiratory tract by opportunistic bacterial pathogens residing in the nasopharynx [7, 8, 9].

The bacterial pathogens most frequently isolated from pneumonic lungs in BRDC cases are M. haemolytica, P. multocida, H. somni, and M. bovis [10, 11, 12]. Trueperella pyogenes is also frequently recovered, particularly in chronic or suppurative cases [10, 13]. While these bacteria can act as primary pathogens under conditions of profound stress or immunosuppression, their pathogenic potential is greatly amplified in the context of viral coinfection [14, 15]. The clinical presentation ranges from acute fibrinous pleuropneumonia, classically associated with M. haemolytica serotype A1, to chronic caseonecrotic pneumonia often linked to M. bovis [16, 17].

The widespread use of antimicrobials for metaphylaxis and treatment of BRDC has exerted intense selective pressure, driving the evolution and dissemination of resistance determinants among these bacterial populations [18, 19]. Multidrug resistance (MDR), defined as resistance to three or more antimicrobial classes, is now a common finding in BRDC bacterial isolates worldwide [20, 21]. Understanding the mechanisms of resistance and the genetic elements responsible for their dissemination is critical for developing effective control strategies and preserving the efficacy of remaining therapeutic options [22, 23].

Primary Bacterial Pathogens

Mannheimia haemolytica

M. haemolytica is a Gram-negative coccobacillus belonging to the family Pasteurellaceae and is considered the most important bacterial pathogen in the BRDC complex in North America [12, 23]. It is a normal commensal of the bovine nasopharynx and tonsillar crypts. Under conditions of stress or viral infection, the organism proliferates, is inhaled into the lungs, and induces a severe, fulminant fibrinous pleuropneumonia [14, 24].

The primary virulence factor of M. haemolytica is a secreted leukotoxin (LktA), a member of the repeats-in-toxin (RTX) family. This exotoxin is cytotoxic to ruminant leukocytes, including neutrophils, macrophages, and lymphocytes, by forming pores in their plasma membranes [24]. The binding specificity for ruminant cells is conferred by the interaction of LktA with the CD18 subunit of beta-2 integrins. The release of leukotoxin triggers an explosive inflammatory response, characterized by the release of proinflammatory cytokines, reactive oxygen species, and degradative enzymes from lysed phagocytes, which paradoxically contributes to much of the tissue damage observed in the lung [9, 24]. Additional virulence determinants include a polysaccharide capsule that inhibits phagocytosis, fimbriae for adherence, and lipopolysaccharide (LPS) which acts as an endotoxin [24].

Serotyping based on capsular polysaccharide antigens identifies 12 serotypes, with serotypes A1 and A6 being most commonly associated with BRDC [25]. Isolates from diseased lungs predominantly express serotype A1, while A2 is more frequently isolated from the nasopharynx of healthy animals [26]. The transition from a commensal to a pathogenic state is associated with a shift in serotype and upregulation of LktA production.

Pasteurella multocida

P. multocida is another Gram-negative coccobacillus in the Pasteurellaceae family. It is a ubiquitous commensal of the upper respiratory tract and is a common secondary invader in BRDC [11, 23]. While often considered less virulent than M. haemolytica, it is a frequent isolate from both acute and chronic cases of bovine pneumonia, and its role in the disease complex is increasingly recognized [27, 10]. In many global surveillance studies, including those from the Iberian Peninsula and China, P. multocida has been detected at rates comparable to or exceeding those of M. haemolytica [1, 11]. The detection rate of P. multocida in clinical samples from Quebec, Canada was also high, underscoring its significance [28].

P. multocida is classified into five capsular serogroups (A, B, D, E, F) and 16 somatic serotypes. The majority of bovine respiratory isolates belong to capsular serogroup A [10, 29]. Key virulence factors include a hyaluronic acid capsule which provides antiphagocytic properties, LPS, and several outer membrane proteins involved in adherence and iron acquisition [29, 21]. A major virulence-associated factor is the dermonecrotic toxin (PMT), though its role in bovine pneumonia is less clear than in atrophic rhinitis of swine.

Recent genomic analyses of P. multocida isolates from BRDC cases have revealed a high degree of genetic diversity and the presence of mobile genetic elements, particularly ICEs, that carry multiple AMR genes [30, 29, 21]. These ICEs are central to the pathogen's capacity to acquire and disseminate resistance.

Histophilus somni

H. somni (formerly Haemophilus somnus) is a Gram-negative coccobacillus in the Pasteurellaceae family. It is a fastidious, slow-growing organism that is a commensal of the bovine reproductive and upper respiratory tracts [12, 23]. In BRDC, H. somni causes a suppurative bronchopneumonia and is also associated with other systemic diseases, including thrombotic meningoencephalomyelitis (TME), myocarditis, and arthritis [10, 31].

Virulence factors include a phase-variable, antigenically complex lipooligosaccharide (LOS) that is critical for intracellular survival within phagocytes and for resisting complement-mediated killing [31, 23]. H. somni also produces an immunoglobulin binding protein (IgBP) that binds host IgG, potentially interfering with opsonization, and a fibronectin-binding protein that facilitates adherence to host cells [31].

H. somni is a well-documented biofilm-forming organism [22]. Biofilm formation is a significant virulence mechanism that contributes to chronic infection and resistance to antimicrobial therapy and host immune defenses. The ability of H. somni to form biofilms in vivo has been demonstrated, linking this phenotype to persistent disease [22, 31]. The LOS and type IV pili are known to contribute to the biofilm matrix.

Mycoplasma bovis

M. bovis is a cell-wall-deficient bacterium belonging to the class Mollicutes. It is a significant and increasingly recognized pathogen in BRDC, particularly in chronic, caseonecrotic pneumonia and arthritis [32, 33, 34]. Unlike the other primary bacterial agents, M. bovis lacks a cell wall, rendering it intrinsically resistant to beta-lactam antimicrobials [32]. Its prevalence has been documented to be high in many studies. In a large Chinese study, the positivity rate for Mycoplasma spp. was 38.9%, with M. bovis accounting for 7.74% of samples [10]. In samples from Quebec, M. bovis was also frequently detected [28]. In Spain, M. bovis was found in 53.6% of farms studied [11].

The pathogenesis of M. bovis is complex and not fully understood. Key virulence mechanisms include the presence of highly variable surface lipoproteins (Vsps) that undergo phase and size variation, allowing the organism to evade the host immune response [32, 33]. M. bovis also produces hydrogen peroxide and superoxide radicals, which cause oxidative damage to host cells, and has been shown to form biofilms in vitro [22]. This biofilm-forming capacity likely contributes to its persistence in the face of antimicrobial therapy [22, 32].

The organism is an obligate parasite and is highly adapted to the bovine host. Chronic infection is a hallmark, and M. bovis can often be isolated from joints and other tissues in addition to the respiratory tract [32]. The lack of highly effective vaccines and the widespread resistance to multiple antimicrobial classes make management of M. bovis infections particularly challenging [32, 33].

Antimicrobial Resistance Patterns

The extensive use of antimicrobials in feedlot operations has led to a marked increase in resistance among BRDC bacterial pathogens. Resistance is documented across all major antimicrobial classes used for treatment and metaphylaxis, including tetracyclines, macrolides, fluoroquinolones, phenicols, and cephalosporins [18, 19, 20].

Integrative and Conjugative Elements (ICEs)

A principal mechanism for the dissemination of AMR genes among Pasteurellaceae is through ICEs. These mobile genetic elements are integrated into the bacterial chromosome but can excise, transfer via conjugation to recipient bacteria, and reintegrate into the new host genome [18, 21]. These large elements often carry multiple resistance genes, conferring MDR in a single transfer event.

In M. haemolytica, P. multocida, and H. somni, ICEs have been shown to carry resistance genes for tetracyclines [tet(H), tet(R)], macrolides [msr(E), mph(E)], aminoglycosides [aadA25, aph(3)-Ia], sulfonamides (sul2), and phenicols (floR) [18, 21]. The presence and composition of these ICEs are dynamic. In a study of Canadian feedlots, the emergence of a M. haemolytica strain carrying all 13 PCR-tested AMR genes, including aadA31 and blaROB-1, was documented in a single year, highlighting the rapid evolution of resistance [18].

Macrolide Resistance

Macrolide resistance is of particular concern due to the widespread use of tulathromycin and gamithromycin for metaphylaxis and treatment. Resistance is commonly mediated by two co-expressed genes carried on ICEs: msr(E), encoding a macrolide efflux pump, and mph(E), encoding a macrolide phosphotransferase that inactivates the drug [18, 19]. The prevalence of macrolide resistance in M. haemolytica isolates from diseased cattle has been reported to exceed 90% in some regions [19].

Tetracycline Resistance

Tetracycline resistance is nearly ubiquitous among M. haemolytica and P. multocida isolates. The primary determinant is the ribosomal protection protein gene tet(H), which is also encoded on ICEs [18]. Resistance rates to tetracycline in California dairy operations were found to be 74% for P. multocida and 34% for M. haemolytica [20].

Fluoroquinolone Resistance

While less prevalent than macrolide or tetracycline resistance, fluoroquinolone resistance is an emerging concern. Resistance arises primarily through point mutations in the quinolone resistance-determining regions (QRDRs) of the DNA gyrase (gyrA) and topoisomerase IV (parC) genes. Plasmid-mediated quinolone resistance (PMQR) genes, such as qnr, have also been identified in some isolates [18].

Beta-Lactam Resistance

Resistance to beta-lactams is less common in M. haemolytica and P. multocida but is observed. The primary mechanism is the production of beta-lactamases, with blaROB-1 being the most frequently detected enzyme [18, 20]. Resistance to penicillin was reported at 43% for M. haemolytica in a dairy antibiogram study [20].

Role of Biofilms in AMR

Bacterial biofilms are structured communities of cells encased in a self-produced extracellular polymeric substance (EPS). All four major bacterial BRDC pathogens, M. haemolytica, P. multocida, H. somni, and M. bovis, have demonstrated biofilm-forming capacity in vitro [22]. Biofilm formation is considered a critical factor in the pathogenesis of chronic, non-responsive infections.

The EPS matrix acts as a physical barrier, limiting the penetration of antimicrobials. Additionally, bacteria within biofilms exhibit a reduced metabolic rate and altered gene expression, rendering them less susceptible to antimicrobials that target actively dividing cells. This physiological state, known as persistence, allows the population to survive exposure to otherwise lethal drug concentrations. Upon cessation of therapy, these persister cells can re-emerge and cause recrudescence of infection [22]. The association of H. somni biofilms with clinical disease in feedlot cattle has been supported by experimental evidence, and it is hypothesized that the ability to form biofilms is a major contributor to antimicrobial treatment failure in BRDC [22].

Diagnostic Approaches for Bacterial Pathogens and AMR

Accurate and rapid identification of the bacterial pathogens involved in a BRDC outbreak is essential for guiding appropriate antimicrobial therapy. Traditional culture and antimicrobial susceptibility testing (AST), while still valuable, have limitations, including a long turnaround time and suboptimal sensitivity for fastidious organisms like H. somni and M. bovis [35, 36].

Multiplex Real-Time PCR

Multiplex real-time PCR (qPCR) assays have become the standard for the rapid detection and quantitation of BRDC pathogens. These assays can simultaneously detect multiple bacterial and viral targets from a single sample (e.g., deep nasopharyngeal swab, bronchoalveolar lavage fluid, or lung tissue) [37, 27, 13, 35].

Commercial and laboratory-developed multiplex qPCR panels can detect M. haemolytica, P. multocida, H. somni, and M. bovis, among other agents [27, 28, 11]. These assays offer high sensitivity and specificity, and results are available within a few hours. The development of assays using multiple thermocycling platforms, including both block-based and rotary-based systems, has increased their accessibility [35]. Recent advances in hybridization capture sequencing and metagenomic sequencing offer even broader pathogen detection and the ability to simultaneously profile the resistome from clinical samples [38, 39, 40].

Antimicrobial Susceptibility Testing

While PCR can detect resistance genes (e.g., tet(H), msr(E), mph(E)), phenotypic AST remains the gold standard for determining the clinical susceptibility profile of an isolate [18, 20]. Standardized methods, such as broth microdilution (e.g., Sensititre panels) and disk diffusion, are employed to determine minimum inhibitory concentrations (MICs) [19, 20].

Cumulative antimicrobial susceptibility testing (CAST) data, or antibiograms, are increasingly used to monitor resistance trends at the farm, regional, and national levels [20]. These data are essential for informing empirical treatment choices and tracking the emergence of MDR.

Detection of AMR Genes

Molecular methods, including conventional PCR and real-time PCR, are used to detect specific AMR genes within bacterial isolates or directly from clinical samples [18, 41]. The detection of ICE core genes can serve as a marker for MDR potential [18]. Recombinase polymerase amplification (RPA) assays represent a promising isothermal technology for targeted detection of bacterial pathogens and AMR genes at or near the point of care [41].

Epidemiology and Global Surveillance

The prevalence and AMR profiles of BRDC bacterial pathogens exhibit significant geographic and temporal variation.

In North America, M. haemolytica has historically been the dominant pathogen, but the prevalence of P. multocida and M. bovis is increasing [28, 19]. A study in Alberta, Canada, found that 100% of M. haemolytica isolates from BRDC cases were resistant to at least one antimicrobial class, with 47.2% of all isolates showing resistance to four or five classes [19]. In California dairies, a farm-level effect was found to be a significant factor in the probability of isolating a non-susceptible strain [20]. In Quebec, bacterial agents were more commonly detected than viruses in clinical respiratory samples [28].

In Europe, studies from Spain and Serbia have documented high prevalence rates of P. multocida (55.6% and 72.9%, respectively) [11, 42]. In Spain, M. bovis was also highly prevalent at 53.6% [11]. Resistance to tetracyclines was common, and P. multocida isolates from Spanish feedlots were found to carry ICEs with AMR gene cargo [21].

In China, large-scale epidemiological investigations have identified P. multocida serotypes A and D, along with M. bovis, as prominent pathogens [1, 10]. Coinfections among bacteria, M. bovis, and viruses (e.g., BVDV, BoHV-1) were a hallmark of severe cases, and certain pathogen pairings were significantly associated [10]. Trueperella pyogenes was identified as a significant contributor to caseous necrotizing pneumonia [10].

Antimicrobial Stewardship and Alternative Strategies

The rise of AMR in BRDC pathogens necessitates a shift toward improved antimicrobial stewardship. This includes:

Targeted Diagnosis: Using multiplex qPCR and AST to guide treatment rather than relying on empirical blanket therapy.
Metaphylaxis Judicious Use: Limiting metaphylactic antimicrobial use to high-risk cattle on arrival and considering non-antibiotic alternatives for low to moderate risk animals [43, 44].
Vaccination: Implementing effective vaccination programs against viral (e.g., BRSV, BHV-1, BPIV-3) and bacterial pathogens (e.g., M. haemolytica leukotoxin toxoid) to reduce disease incidence [45, 46, 47, 48].
Management Practices: Reducing stress through appropriate weaning protocols, minimizing commingling, providing adequate ventilation, and ensuring proper nutrition [49, 50, 51].
Non-Antibiotic Alternatives: Research into alternatives such as antimicrobial peptides (e.g., cathelicidins), plant-based therapeutics, probiotics, and immune modulators is promising [52, 53, 54, 55].

A decision tree for managing BRDC in feedlot cattle based on diagnostic data is illustrated below.

graph TD
    A[Arrival: High risk calf], > B{Metaphylaxis Strategy};
    B, >|Antimicrobial| C[Administer based on known resistence profile / antibiogram];
    B, >|Non-Antibiotic| D[Administer immune modulator (e.g., Zelnate)];
    C, > E[Monitor for clinical signs (fever, depression, inappetence)];
    D, > E;
    E, > F{Clinical signs present?};
    F, >|No| G[Continue routine pen surveillance];
    F, >|Yes| H[Collect deep nasopharyngeal swab / BAL];
    H, > I[Perform multiplex qPCR + AST];
    I, > J{Pathogen identified?};
    J, >|M. haemolytica / P. multocida / H. somni| K{Resistance profile known?};
    K, >|Yes| L[Select targeted antimicrobial (e.g., tulathromycin if susceptible)];
    K, >|No| M[Select therapy based on local/regional antibiogram data];
    L, > N[Administer treatment and monitor response];
    M, > N;
    J, >|M. bovis| O[Select active antimicrobial (e.g., florfenicol, enrofloxacin; avoid beta-lactams)];
    O, > N;
    N, > P{Clinical improvement within 48-72h?};
    P, >|Yes| Q[Complete treatment course];
    P, >|No| R[Re-culture/re-test for resistance];
    R, > S{Resistance confirmed?};
    S, >|Yes| T[Switch antimicrobial class based on new AST results];
    S, >|No| U[Re-evaluate for non-bacterial causes (viral, fungal, management)];
    T, > N;

Conclusions

Bacterial pathogens remain the primary cause of clinical disease and mortality in BRDC, with M. haemolytica, P. multocida, H. somni, and M. bovis being the most significant. The relentless selection pressure from antimicrobial use has resulted in widespread and increasing resistance, particularly to macrolides and tetracyclines, mediated largely by the horizontal transfer of ICEs. Biofilm formation adds an additional layer of complexity, contributing to therapeutic failure in chronic cases.

Effective control of BRDC in the face of rising AMR requires a multifaceted approach. This includes the adoption of rapid molecular diagnostics for pathogen identification and resistance profiling, the implementation of robust antimicrobial stewardship programs guided by cumulative susceptibility data, and the integration of preventative strategies such as vaccination and environmental management. Continued research into novel therapeutic alternatives, including antimicrobial peptides and immunomodulators, is urgently needed to reduce reliance on conventional antibiotics and ensure the long-term sustainability and welfare of beef production systems.

References

[1] Zhou, Y., Guo, T., Zhao, H., et al. Epidemiological Investigation and Phylogenetic Analysis of Bovine Respiratory Disease Complex in Northern China. Veterinary Medicine and Science.

[2] BOVINE RESPIRATORY DISEASE COMPLEX (BRD). International Journal of Veterinary Science.

[3] Kurćubić, V., Đoković, R., Ilic, Z., et al. Etiopathogenesis and economic significance of bovine respiratory disease complex (BRDC).

[4] Baptista, A. L., Rezende, A., Fonseca, P. D. A., et al. Bovine respiratory disease complex associated mortality and morbidity rates in feedlot cattle from southeastern Brazil. Journal of Infection in Developing Countries.

[5] Kumar, P., Yadav, A., kesh, L., et al. Bovine Respiratory Disease Complex – A Review. International Journal of Current Microbiology and Applied Sciences.

[6] Schneider, M., Tait, R., Busby, W. D., et al. An evaluation of bovine respiratory disease complex in feedlot cattle: Impact on performance and carcass traits using treatment records and lung lesion scores. Journal of Animal Science.

[7] Grissett, G. P., White, B. J., Larson, R. L. Structured Literature Review of Responses of Cattle to Viral and Bacterial Pathogens Causing Bovine Respiratory Disease Complex. Journal of Veterinary Internal Medicine.

[8] Kirchhoff, J., Uhlenbruck, S., Goris, K., et al. Three viruses of the bovine respiratory disease complex apply different strategies to initiate infection. Veterinary Research.

[9] Srikumaran, S., Kelling, C., Ambagala, A. Immune evasion by pathogens of bovine respiratory disease complex. Animal Health Research Reviews.

[10] Zhou, Y., Shao, Z., Dai, G., et al. Pathogenic infection characteristics and risk factors for bovine respiratory disease complex based on the detection of lung pathogens in dead cattle in northeast China. Journal of Dairy Science.

[11] Santo Tomás, H., T., R., C., G., et al. Bovine Respiratory Disease Complex: Prevalence of the Different Bacteria Involved in Pneumonia in the Iberian Peninsula. Journal of Animal Science and Research.

[12] Griffin, D., Chengappa, M., Kuszak, J., et al. Bacterial pathogens of the bovine respiratory disease complex. The Veterinary clinics of North America. Food animal practice.

[13] Kishimoto, M., Tsuchiaka, S., Rahpaya, S. S., et al. Development of a one-run real-time PCR detection system for pathogens associated with bovine respiratory disease complex. Journal of Veterinary Medical Science.

[14] Gershwin, L., Van Eenennaam, A. L., Anderson, M. L., et al. Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex. PLoS ONE.

[15] Tizioto, P., Kim, J., Seabury, C., et al. Immunological Response to Single Pathogen Challenge with Agents of the Bovine Respiratory Disease Complex: An RNA-Sequence Analysis of the Bronchial Lymph Node Transcriptome. PLoS ONE.

[16] Mehinagic, K., Pilo, P., Vidondo, B., et al. Coinfection of Swiss cattle with bovine parainfluenza virus 3 and Mycoplasma bovis at acute and chronic stages of bovine respiratory disease complex. Journal of Veterinary Diagnostic Investigation.

[17] Kurćubić, V., Djoković, R., Ilic, Z., et al. Bovine Respiratory Disease Complex (BRDC): A review of lung lesions and reducing of quality of carcasses. Biotehnologija u stocarstvu.

[18] Stanford, K., Zaheer, R., Klima, C., et al. Antimicrobial Resistance in Members of the Bacterial Bovine Respiratory Disease Complex Isolated from Lung Tissue of Cattle Mortalities Managed with or without the Use of Antimicrobials. Microorganisms.

[19] Anholt, R. M., Klima, C., Allan, N., et al. Antimicrobial Susceptibility of Bacteria That Cause Bovine Respiratory Disease Complex in Alberta, Canada. Frontiers in Veterinary Science.

[20] Monteiro, H. F., Hoyos-Jaramillo, A., Garzon, A., et al. Antibiogram use on dairy cattle for bovine respiratory disease: A repeated cross-sectional study evaluating antimicrobial susceptibility of Pasteurella multocida and Mannheimia haemolytica. Journal of Dairy Science.

[21] Serna, C., Calderón Bernal, J. M., Torre-Fuentes, L., et al. Integrative and conjugative elements associated with antimicrobial resistance in multidrug resistant Pasteurella multocida isolates from bovine respiratory disease (BRD)-affected animals in Spanish feedlots. Vet Q.

[22] Andrés-Lasheras, S., Zaheer, R., Jelinski, M. D., et al. Role of biofilms in antimicrobial resistance of the bacterial bovine respiratory disease complex. Frontiers in Veterinary Science.

[23] Storoni, C., Preziuso, S., Attili, A., et al. Bacterial Bovine Respiratory Disease: A Comprehensive Review of Etiology, Pathogenesis and Management Strategies. Microbiology Research.

[24] Menghwar, H., Tatum, F. M., Briggs, R. E., et al. Mannheimia haemolytica isogenic capsular and LPS-sialylation gene deletion mutants are attenuated in a calf lung challenge model. Microbiol Spectr.

[25] Iguchi, A., Ueno, Y., Hoshinoo, K., et al. Comprehensive serotyping of Mannheimia haemolytica by a PCR system using the diversity of capsule biosynthesis genes. Sci Rep.

[26] Wang, C., Bai, X., Wang, J., et al. Exploring the diagnostic landscape of Mannheimia haemolytica: technologies, applications, and perspectives. Front Microbiol.

[27] Hao, F., Tao, C., Xiao, R., et al. Development of a Multiplex Real-Time PCR Assay for the Detection of Eight Pathogens Associated with Bovine Respiratory Disease Complex from Clinical Samples. Microorganisms.

[28] Buczinski, S., Broes, A., Savard, C. Frequency of Bovine Respiratory Disease Complex Bacterial and Viral Agents Using Multiplex Real-Time qPCR in Quebec, Canada, from 2019 to 2023. Veterinary Sciences.

[29] Ahmadi, A., Oma, V. S., Ånestad, L. M., et al. Genomic diversity and virulence of Pasteurella multocida in Norwegian calves. Microb Genom.

[30] Harhay, G., Harhay, D., Bono, J., et al. Closed Genome Sequences and Antibiograms of 16 Pasteurella multocida Isolates from Bovine Respiratory Disease Complex Cases and Apparently Healthy Controls. Microbiology Resource Announcements.

[31] Harhay, G., Harhay, D., Bono, J., et al. Closed Genome Sequences of Seven Histophilus somni Isolates from Beef Calves with Bovine Respiratory Disease Complex. Genome Announcements.

[32] Rashad, H., Zaghawa, A., Nayel, M., et al. Bovine Respiratory Disease Complex with Special Reference to Mycoplasma bovis in Egypt. Journal of Current Veterinary Research.

[33] Dudek, K., Nicholas, R. A. J. Recent Role of Microorganisms of the Mollicutes Class in the Etiology of Bovine Respiratory Disease. Pathogens.

[34] Horwood, P. F., Schibrowski, M. L., Fowler, E. V., et al. Is Mycoplasma bovis a missing component of the bovine respiratory disease complex in Australia? Australian Veterinary Journal.

[35] Loy, J. D., Leger, L., Workman, A. M., et al. Development of a multiplex real-time PCR assay using two thermocycling platforms for detection of major bacterial pathogens associated with bovine respiratory disease complex from clinical samples. Journal of Veterinary Diagnostic Investigation.

[36] Cornelissen, J., de Bree, F. M., van der Wal, F. J., et al. Mycoplasma detection by triplex real-time PCR in bronchoalveolar lavage fluid from bovine respiratory disease complex cases. BMC Veterinary Research.

[37] Li, L., Jiang, Q., Li, S., et al. Establishment of a multiplex qPCR assay for the detection of pathogens associated with bovine respiratory disease complex. Frontiers in Veterinary Science.

[38] Ambrose, R., Blakebrough-Hall, C., Gravel, J., et al. Characterisation of the Upper Respiratory Tract Virome of Feedlot Cattle and Its Association with Bovine Respiratory Disease. Viruses.

[39] Abedien, Z. U., Lean, I. J., Djordjevic, S. P., et al. Next-generation detection in bovine respiratory and enteric diseases: metagenomic and amplicon sequencing insights into microbial diversity. Front Vet Sci.

[40] Russell, J. N., Kos, D., Yacoub, E., et al. Enhanced metagenomic surveillance for bovine respiratory disease pathogens and antimicrobial resistance by hybridization capture sequencing. Appl Environ Microbiol.

[41] Funk, T., McLeod, L., Zaheer, R., et al. Evaluation of recombinase polymerase amplification assays for targeted detection of bovine respiratory disease bacterial pathogens and antimicrobial-resistance genes in feedlot calves. J Vet Diagn Invest.

[42] Matović, K., Kurćubić, V., Đoković, R., et al. Paradigm of coinfection with viral and bacterial agents causing bovine respiratory disease complex (BRDC) in Central Serbia. Acta Agriculturae Serbica.

[43] Regev-Shoshani, G., McMullin, B., Nation, N., et al. Non-inferiority of nitric oxide releasing intranasal spray compared to sub-therapeutic antibiotics to reduce incidence of undifferentiated fever and bovine respiratory disease complex in low to moderate risk beef cattle arriving at a commercial feedlot. Preventive Veterinary Medicine.

[44] Spore, T., Montgomery, S., Hanzlicek, G., et al. Zelnate on Arrival Could Decrease the Likelihood of Subsequent Pulls in Suspect Bovine Respiratory Disease Complex Cases.

[45] Yarnall, M., Amovilli, F., Assié, S., et al. Identifying and addressing barriers and opportunities for bovine respiratory disease complex vaccination: a consensus paper on practical recommendations for best practise vaccination. Frontiers in Veterinary Science.

[46] Santo Tomás, H., Barreto, M., V., B., et al. Bovine Respiratory Disease Complex: Prevalence of the Main Respiratory Viruses Involved in Pneumonia in Spain. Journal of Animal Science and Research.

[47] Theurer, M., Larson, R., White, B. Systematic review and meta-analysis of the effectiveness of commercially available vaccines against bovine herpesvirus, bovine viral diarrhea virus, bovine respiratory syncytial virus, and parainfluenza type 3 virus for mitigation of bovine respiratory disease complex in cattle. Journal of the American Veterinary Medical Association.

[48] Kurćubić, V., Ilic, Z., Djoković, R., et al. Vaccination and medication against bovine respiratory disease complex (BRDC).

[49] Sáfár, J., Hejel, P., Vass-Bognár, B., et al. The impact of environmental factors on bovine respiratory disease complex in dairy calves - a review. Acta Veterinaria Brno.

[50] Wisnieski, L., Amrine, D., Cernicchiaro, N., et al. Weather conditions associated with death attributed to bovine respiratory disease complex in high-risk auction market-sourced male beef calves. American Journal of Veterinary Research.

[51] Cusack, P. Evaluation of practices used to reduce the incidence of bovine respiratory disease in Australian feedlots (to November 2021). Australian Veterinary Journal.

[52] Plant-Based Therapeutics Against Bovine Respiratory Disease Complex (BRDC): Emerging Alternatives in Livestock Health Management. Pakistan Veterinary Journal.

[53] Cornejo, S., Barber, C., Thoresen, M., et al. Synthetic antimicrobial peptides Bac-5, BMAP-28, and Syn-1 can inhibit bovine respiratory disease pathogens in vitro. Frontiers in Veterinary Science.

[54] Gharban, H. Molecular detection of Enterobacter hormaechei in bovine respiratory disease. Veterinární Medicína.

[55] Yan, F., Zhang, Z., Zhan, X., et al. Immune pre-stimulation by injected yeast beta-glucan as a strategy to prevent calf diarrhea and bovine respiratory disease during the first 74 days of age. Front Cell Infect Microbiol.

[56] Werid, G. M., Ibrahim, Y. M., Girmay, G., et al. Bovine adenovirus prevalence and its role in bovine respiratory disease complex: a systematic review and meta-analysis. The Veterinary Journal.

[57] Kamdi, B., Singh, R., Singh, V., et al. Investigating bovine coronavirus in Indian calves: Incidence, molecular evidence, and pathological role in bovine respiratory disease complex (BRDC). Iranian Journal of Veterinary Research.

[58] Hegazy, A. A., Nakai, M., Fuke, N., et al. Detection of bovine respiratory disease complex related pathogens in nasopharynx-associated lymphoid tissue. Journal of Veterinary Diagnostic Investigation.

[59] Ozcan, U., Tutuncu, M. The Effect of Florfenicol Given by Nebulization in the Treatment of Naturally Infected Calves With Bovine Respiratory Disease Complex: Randomized Clinical Study. Veterinary Medicine and Science.

[60] Milićević, V., Šolaja, S., Glišić, D., et al. Bovine Parainfluenza Virus 3 and Bovine Respiratory Syncytial Virus: Dominant Viral Players in Bovine Respiratory Disease Complex among Serbian Cattle. Animals.

[61] Farooq, M. U., Mubeen, M., Danial, M., et al. ARTIFICIAL INTELLIGENCE AND DEEP LEARNING FOR AUTOMATED DIAGNOSIS OF BOVINE RESPIRATORY DISEASE COMPLEX FROM INFRARED THERMOGRAPHY AND AUDIO SIGNAL. Biology and Biotechnology Communications.

[62] Russell, T., Sulçe, M., Hoda, A., et al. Detection of viruses associated with bovine respiratory disease complex in samples collected from Albanian cattle during 2022/2023. Access Microbiology.

[63] Paksoy, Y., İnce, Ö. B., Özgür, E. G., et al. Seroprevalence of viral pathogens associated with bovine respiratory disease complex and biosecurity-related risk factors in cattle farms in Türkiye. Tropical Animal Health and Production.

[64] Ban, Y., Zhang, F., Zhang, Z., et al. Molecular investigation and viral load analysis of bovine respiratory syncytial virus in cattle with bovine respiratory disease complex in Inner Mongolia, China. Frontiers in Cellular and Infection Microbiology.

[65] Molecular Characterization of Important Viruses Contributing to Bovine Respiratory Disease Complex in Türkiye. Pakistan Veterinary Journal.

[66] Werid, G. M., Miller, D., Hemmatzadeh, F., et al. An overview of the detection of bovine respiratory disease complex pathogens using immunohistochemistry: emerging trends and opportunities. Journal of Veterinary Diagnostic Investigation.

[67] Ferraro, S., Fecteau, G., Dubuc, J., et al. Scoping review on clinical definition of bovine respiratory disease complex and related clinical signs in dairy cows. Journal of Dairy Science.

[68] Fergusson, M., Maley, M., Geraghty, T., et al. Validation of a multiplex-tandem RT-PCR for the detection of bovine respiratory disease complex using Scottish bovine lung samples. The Veterinary Journal.

[69] Zhang, J., Wang, W., Yang, M., et al. Development of a One-Step Multiplex Real-Time PCR Assay for the Detection of Viral Pathogens Associated With the Bovine Respiratory Disease Complex. Frontiers in Veterinary Science.

[70] Akyüz, E., Merhan, O., Aydın, U., et al. Pentraxin-3, endothelin-1, some biochemical parameters and hematology in bovine respiratory disease complex. Iranian Journal of Veterinary Research.

[71] Uprety, T., Sreenivasan, C. C., Thomas, M., et al. Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex. Virology.

[72] Li, J., Zhu, Y., Shoemake, B., et al. A systematic review of the utility of biomarkers as aids in the early diagnosis and outcome prediction of bovine respiratory disease complex in feedlot cattle. Journal of Veterinary Diagnostic Investigation.

[73] Oviedo Pastrana, M. E., Carrascal-Triana, E., Doria Ramos, M., et al. Seroprevalence and associated factors of viral agents of the bovine respiratory disease complex in buffaloes of Colombia. Ciência Rural.

[74] Guo, T., Zhang, J., Chen, X., et al. Investigation of viral pathogens in cattle with bovine respiratory disease complex in Inner Mongolia, China. Microbial Pathogenesis.

[75] Willett, M., Campbell, M., Schoenfeld, E., et al. Review of Associated Health Benefits of Algal Supplementation in Cattle with Reference to Bovine Respiratory Disease Complex in Feedlot Systems. Animals.

[76] Lapczak, J. C. O., Rossi, P. S., Thomaz, G. R., et al. Therapeutic efficacy of marbofloxacin and ceftiofur in feedlot steers with bovine respiratory disease complex. Acta Veterinaria Brasilica.

[77] Değirmençay, Ş., Kırbaş, A., Aydın, H., et al. Evaluation of Serum Iron and Ferritin Levels as Inflammatory Markers in Calves with Bovine Respiratory Disease Complex. Acta Veterinaria.

[78] Pansri, P., Katholm, J., Krogh, K., et al. Evaluation of novel multiplex qPCR assays for diagnosis of pathogens associated with the bovine respiratory disease complex. The Veterinary Journal.

[79] Susilo, J., Siswanto, J., Karmil, T., et al. 8. The Role of Bovine Viral Diarrhea Virus In Bovine Respiratory Disease Complex In Cattle Import Livestock At 2019 Periode. Jurnal Medika Veterinaria.

[80] McDaneld, T., Kuehn, L., Keele, J. Evaluating the microbiome of two sampling locations in the nasal cavity of cattle with bovine respiratory disease complex (BRDC). Journal of Animal Science.

[81] Nakamura, M., Koyama, T., Matsui, Y., et al. Serum haptoglobin fluctuation in calves with bovine respiratory disease complex. Japanese Journal of Large Animal Clinics.

[82] Groves, J., Goldsmith, T., Carlson, J. How Forces of a Complex Adaptive System Affect Ability to Control Bovine Respiratory Disease in Feeder Cattle. The Veterinary clinics of North America. Food animal practice.

[83] Cavirani, S. Immunization of calves and herd immunity to Bovine Respiratory Disease Complex (BRDC).

[84] Behura, S., Tizioto, P., Kim, J., et al. Tissue Tropism in Host Transcriptional Response to Members of the Bovine Respiratory Disease Complex. Scientific Reports.

[85] Love, W., Lehenbauer, T., Van Eenennaam, A. L., et al. Sensitivity and specificity of on-farm scoring systems and nasal culture to detect bovine respiratory disease complex in preweaned dairy calves. Journal of Veterinary Diagnostic Investigation.

[86] Adekunle, A., Kaniyamattam, K., Cooke, R. 388 Epidemiological risk factor dynamics of Bovine Respiratory Disease in U.S. beef production systems. Journal of Animal Science.

[87] Shoemake, B., Ley, B., Newcomer, B., et al. Efficacy of Oral Administration of Sodium Iodide to Prevent Bovine Respiratory Disease Complex. Journal of Veterinary Internal Medicine.

[88] Sun, C. Recent Advances in Prevention and Control Strategies for Bovine Respiratory Disease. Theoretical and Natural Science.

[89] Kramer, L., Mayes, M. S., Fritz-Waters, E., et al. Evaluation of responses to vaccination of Angus cattle for four viruses that contribute to bovine respiratory disease complex. Journal of Animal Science.

[90] Kiser, J., Cornmesser, M., Blackburn, R., et al. Validating loci associated with bovine respiratory disease complex in pre-weaned Holstein calves. Animal Genetics.

[91] Buczinski, S., Fecteau, G., Dubuc, J., et al. Validation of a clinical scoring system for bovine respiratory disease complex diagnosis in preweaned dairy calves using a Bayesian framework. Preventive Veterinary Medicine.

[92] Schaffer, A., Larson, R., Cernicchiaro, N., et al. The association between calfhood bovine respiratory disease complex and subsequent departure from the herd, milk production, and reproduction in dairy cattle. Journal of the American Veterinary Medical Association.

[93] Ayyoub, N., Mahmoud, A., Khadr, A., et al. Molecular and Epidemiological Studies on Bovine Respiratory Disease Complex (BRDC) with Special Reference to IBR in Alexandria and El-Behera Governorates. Alexandria Journal of Veterinary Sciences.

[94] Kramer, L., Mayes, M. S., Fritz-Waters, E., et al. Vaccination response in Angus calves. Journal.

[95] Patel, N., Patel, R. K., Rajoriya, J. S., et al. Bovine Respiratory Disease Complex: A Critical Review.

[96] Setiyaningsih, S., Shofa, M., Wulansari, R., et al. JSPS-4 Preliminary Investigation of Bovine Respiratory Disease Complex in Indonesia.

[97] Attree, E., ths, B. G., Panchal, K., et al. Identification of DNA methylation markers for age and Bovine Respiratory Disease in dairy cattle: A pilot study based on Reduced Representation Bisulfite Sequencing. Communications Biology.

[98] Eyango Tabi, T. G. L., Rouault, M., Potdevin, V., et al. Harnessing uncertainty: A deep mechanistic approach for cautious diagnostic and forecast of Bovine Respiratory Disease. Preventive Veterinary Medicine.

[99] Reid, C., Donlon, J., Rémot, A., et al. Hyper-induction of IL-6 after TLR1/2 stimulation in calves with bovine respiratory disease. PLoS ONE.

[100] El-Sheikh, M. E., El-Mekawy, M. F., Eisa, M. I., et al. Effect of two different commercial vaccines against bovine respiratory disease on cell-mediated immunity in Holstein cattle. Open Veterinary Journal.

[101] Kumar, P., Kumar, A., Yadav, A., et al. Clinico-Therapeutic Studies in Bovine Respiratory Disease Complex in Buffaloes. International Journal of Current Microbiology and Applied Sciences.

[102] Neibergs, H., Seabury, C., Wójtowicz, A., et al. Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves. BMC Genomics.

[103] Mihali, A. M., Dumitrescu, E. Bovine respiratory syncytial virus and bovine parainfluenza virus type 3 as common causes of respiratory disease in cattle. Romanian Journal of Veterinary Sciences.

[104] Rahpaya, S. S., Tsuchiaka, S., Kishimoto, M., et al. Dembo polymerase chain reaction technique for detection of bovine abortion, diarrhea, and respiratory disease complex infectious agents in potential vectors and reservoirs. Journal of Veterinary Sciences.

[105] Jones, C., Chowdhury, S. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Animal Health Research Reviews.

[106] Centeno-Martinez, R. E., Klopp, R., Koziol, J., et al. Dynamics of the nasopharyngeal microbiome of apparently healthy calves and those with clinical symptoms of bovine respiratory disease from disease diagnosis to recovery. Frontiers in Veterinary Science.

[107] Theurer, M., White, B., Larson, R., et al. Relationship between rectal temperature at first treatment for bovine respiratory disease complex in feedlot calves and the probability of not finishing the production cycle. Journal of the American Veterinary Medical Association.

[108] Liu, L., Xiang, J., Shi, Y., et al. Development and application of a dual RT-qPCR assay for the differential detection of bovine rhinitis virus genotypes A and B. J Virol Methods.

[109] Sang, H., Kim, T., Kumar, R., et al. Novel BPI3Vc-vectored chimeric BVDV antigens elicit broadly neutralizing antibodies in cattle. Front Immunol.

[110] Makratzakis, L. C., Velasco, J. A., Stegelmeier, N. C., et al. Peripheral leukocyte transcriptomic changes in preweaned Holstein heifer calves with varying stages of Bovine Respiratory Disease. PLoS One.

[111] Buczinski, S., Gomes, V., Vergnes, G., et al. Lung ultrasonography used as a diagnostic test for respiratory disease diagnosis in calves: systematic review and meta-analysis using a Bayesian latent-class modelling approach. J Dairy Sci.

[112] Liao, J., Yang, X., Li, R., et al. Development of an indirect enzyme-linked immunosorbent assay based on the nucleocapsid protein of bovine parainfluenza virus type 3. Front Cell Infect Microbiol.

[113] Wester, R. J., Samera, G. J., Walcott, J. R., et al. Molecular surveillance of Mycoplasmopsis bovis across dairy farms in Western Canada and 16s microbiome assessment in pneumonic calves. J Dairy Sci.

[114] Doğan, E. Effects of diclofenac sodium and tilmicosin on cardiac biomarkers in calves with bovine respiratory disease complex. Acta Vet Hung.

[115] Li, Y., Wen, D., Zhou, Z., et al. [A CRISPR-Cas13a-based amplification-free electrochemical biosensor for rapid detection of bovine viral diarrhea virus]. Sheng Wu Gong Cheng Xue Bao.

[116] Ren, L., Tian, C., Shen, C., et al. Epidemiological Insights Into BVDV and IBRV in Feeder Cattle After Cross-Regional Transport in China 2022-2024: Coinfection Dynamics and Implications for BRDC Control. Transbound Emerg Dis.

[117] Yu, R., Yang, W., Liu, X., et al. Development and evaluation of a P. multocida A-M. haemolytica A6-rLkt combined vaccine for enhanced control of bovine respiratory disease complex. Microb Pathog.

[118] Foster, R. C., Gouvêa, V. N., Beck, M. R., et al. Effects of gut barrier dysfunction during a viral respiratory disease challenge on immune function of feedlot beef calves. J Anim Sci.

[119] Werid, G. M., Ibrahim, Y. M., Wubshet, A. K., et al. Bovine Respiratory Mycoplasmas and the Commensal-Pathogen Continuum: A Systematic Review of Vaccines and Diagnostic Approaches. Animals (Basel).

[120] Amarbayasgalan, S., Takahashi, T., Sugiura, Y., et al. Bovine respiratory syncytial virus utilizes the human insulin-like growth factor 1 receptor in the late stages of infection. J Gen Virol.

[121] Garzon, A., Miramontes, C., Weimer, B. C., et al. Characterizing the nasopharyngeal microbiome and resistome of dairy cattle with and without bovine respiratory disease. Microbiol Spectr.

[122] Laschinger, J., Spergser, J., Taxacher, B., et al. Bacteria identified from deep nasopharyngeal swabs and non-endoscopic bronchoalveolar lavage in calves on farms with a history of bronchopneumonia. Acta Vet Scand.

[123] Sekine, W., Katayama, M., Ohira, K., et al. A serological survey of influenza D virus infection in cattle in Hokkaido, Japan. J Vet Med Sci.

[124] Snyder, E. R., Younes, J. A., Bird, E. M., et al. Investigating contagious transmission of Mannheimia haemolytica in feedlot calves by leveraging whole genome sequences of a unique isolate collection. Vet Microbiol.

[125] Sang, H., Kim, T., Kumar, R., et al. Novel BPI3Vc-vectored surface displayed fusion and hemagglutinin-neuraminidase antigens elicit broadly neutralizing antibodies in cattle. Front Immunol.

[126] Pengpanun, S., Panyapan, S., Singhla, T. Comparative Efficacy of Tulathromycin and Ceftiofur for Treating Undifferentiated BRDC and Tulathromycin Metaphylaxis in Dairy Cattle. Antibiotics (Basel).

[127] Yang, F., Liu, F., Zhai, Y., et al. Plasma untargeted lipidomics based on UHPLC-Orbitrap-MS reveals potential biomarkers and the pathogenesis involved in Mycoplasma bovis pneumonia. Vet Microbiol.

[128] Erickson, N. E. N., Ware, T., Campbell, J., et al. Comparison of pre-weaning bovine respiratory disease treatment rates between non-vaccinated control and variably primed and boosted beef calves receiving commercially available bovine coronavirus vaccines. Can Vet J.

[129] Werid, G. M., Hemmatzadeh, F., Batterham, T., et al. Metagenomic and metatranscriptomic analyses reveal microbial dysbiosis and bacteria-virus interactions in the lungs of Australian feedlot cattle with bovine respiratory disease. Vet Microbiol.

[130] Köse, S., Şehu, A., Gülendağ, E., et al. The effects of preventive measures against neonatal diarrhea and bovine respiratory disease (BRD) on the reproductive and milk production performance of calves in later stages. Tierarztl Prax Ausg G Grosstiere Nutztiere.

[131] Xu, Y., Katayama, M., Ishida, H., et al. Preclinical evaluation of an 8-segmented influenza D virus as a live-attenuated vaccine platform in mice. Vet Microbiol.

[132] Jakes, G. M., Ammons, D. T., Hunter, R., et al. Transport stress induces paradoxical increases in airway inflammatory responses in beef stocker cattle. PLoS One.

[133] Hao, J., Gao, X., Light, C., et al. Genome-wide CRISPR/Cas9 knockout screen identifies host factors essential for bovine parainfluenza virus type 3 replication. Sci China Life Sci.

[134] Wen, S., Zhang, J., Lu, N., et al. Bovine Parainfluenza Virus Type 3 Infection Reprograms the Bovine Serum Lipidome Associated with Phosphatidylinositol Depletion and Sphingolipid Axis Activation. Microorganisms.

[135] Holthausen, D. J., Bickel, K. A., Medina, G. N., et al. Bacterially expressed non-glycosylated recombinant bovine interferon lambda demonstrates antiviral activity against bovine viral diarrhea virus in cell culture. Res Vet Sci.

[136] Davidson, J. L., Maruthumuthu, M. K., Kamel, M., et al. Detection of five viruses commonly implicated with bovine respiratory disease using loop-mediated isothermal amplification. Vet Q.

[137] Wang, J., Li, R., Liu, L., et al. Development and application of a real-time RT-PCR assay for the specific detection of influenza D virus. J Virol Methods.

[138] Doan, T. D., Laohasatian, T., Wu, H. C., et al. Protective efficacy of the recombinantly expressed C-terminal domain of Mannheimia haemolytica leukotoxin in mice and goats. J Vet Res.

[139] West, H. E., Kaplan, B. S., Mast, N. L., et al. Increased expression of the purinergic receptor P2Y6 in the bovine lung following experimental BRSV infection. Vet Immunol Immunopathol.

[140] Rients, E. L., Hansen, S. L., Mcgill, J. L. Impact of bovine respiratory disease on tissue-specific regulation of Zn and vitamin a metabolism and apparent absorption and retention of trace minerals. J Anim Sci.

[141] Magrin, L., Dante, S., Contiero, B., et al. When beef cattle drink less: Automated water intake monitoring as an early warning for respiratory disease during the adaptation period at the fattening unit. Prev Vet Med.

[142] Geng, Y., Jiang, C., Zhang, H., et al. Genome-scale CRISPR screen identifies host factors associated with bovine parainfluenza virus 3 infection. Virulence.

[143] O'Donoghue, S., Waters, S. M., Morris, D. W., et al. A Comprehensive Review: Molecular Diagnostics and Multi-Omics Approaches to Understanding Bovine Respiratory Disease. Vet Sci.

[144] Wang, J., Wang, P., Tian, F., et al. Multi-Epitope-Based Peptide Vaccine Against Bovine Parainfluenza Virus Type 3: Design and Immunoinformatics Approach. Vet Sci.

[145] Moreira, D. M., Rocha, C., Aguirre, R., et al. Associations of diarrhea and bovine respiratory disease with growth, feed intake, and mortality during the preweaning period of Holsteins and beef-on-dairy calves. J Dairy Sci.

[146] Eman, S., Mohai Ud Din, R., Zafar, M. H., et al. Technologies in Biomarker Discovery for Animal Diseases: Mechanisms, Classification, and Diagnostic Applications. Animals (Basel).

[147] Ghahramani, N., Hashemi, A., Panahi, B. Weighted gene co-expression network analysis identifies functional modules related to bovine respiratory disease. PLoS One.

[148] Sanguinetti, V. M., Adams, C., Campbell, J., et al. Benchmarking management practices that impact calf morbidity and mortality in Canadian beef cow-calf herds. Prev Vet Med.

[149] Lawhon, S. D., Burbick, C. R., Krueger, T., et al. Valid and accepted novel bacterial taxa isolated from domestic companion and agricultural animals described in 2024. J Clin Microbiol.

[150] Fernandes, I. L. B., Cantor, M. C., Fonseca, A., et al. The association of lung consolidation in beef × dairy cattle at weaning with feedlot growth performance, carcass characteristics, liver health, and liver microbiome diversity. J Anim Sci.

[151] Abrams, A. N., Kuehn, L. A., Keele, J. W., et al. Evaluation of Nasal Microbial Communities of Beef Calves During Pre-Weaning Outbreak of Bovine Respiratory Disease. Animals (Basel).

[152] Pitters, M., Fritsch, H., Su, A., et al. Application of Bovine Nasal Epithelial Cells as an In Vitro Model for Studying Viral Infection in the Upper Respiratory Tract. Viruses.

[153] Merca, C., Sorin-Dupont, B., Kristensen, A. R., et al. Combining dynamic generalized linear models and mechanistic modelling to optimize treatment strategies against bovine respiratory disease. Vet Res.

[154] Zulauf, B., Pastey, M. K. Field-validated multiplex RT-qPCR for simultaneous detection of bovine respiratory syncytial virus and bovine parainfluenza virus-3 in bovine respiratory samples. Front Vet Sci.

[155] Werid, G. M., Batterham, T., O'Meara, L., et al. Single-dose Pasteurella multocida and Histophilus somni autogenous vaccines administered at induction significantly improved feedlot cattle performance and profitability in Australia. Aust Vet J.

[156] O'Donoghue, S., Waters, S. M., Morris, D. W., et al. A Comprehensive Review: Bovine Respiratory Disease, Current Insights into Epidemiology, Diagnostic Challenges, and Vaccination. Vet Sci.

[157] Kong, F., Zhang, X., Xiao, Q., et al. Heat Shock Protein 70 in Cold-Stressed Farm Animals: Implications for Viral Disease Seasonality. Microorganisms.

[158] Yamada, M., Aly, S. S., Dubrovsky, S., et al. Effects of short-term climatic conditions on the risk of bovine respiratory disease in preweaned calves on California dairies. Prev Vet Med.

[159] Herrick, A. L., Kiser, J. N., White, S. N., et al. Genomic regions associated with bovine respiratory disease in pacific northwest Holstein cattle. Front Vet Sci.

[160] Zhang, S., Liu, G., Guo, A., et al. Maternal antibody transfer efficiency: The impact of M. bovis-BoHV-1 combined vaccine. Virology.

[161] Koizumi, S., Nishi, T., Morioka, K., et al. Development of a Conventional Reverse Transcription-PCR System for Broad Detection of Bovine Rhinitis A Virus. Vet Med Sci.

[162] Herrick, A. L., Kiser, J. N., White, S. N., et al. Genomic Regions Associated with Respiratory Disease in Holstein Calves in the Southern United States. Genes (Basel).

[163] Henderson, J. A., Genther-Schroeder, O. N., Hansen, S. L., et al. The impact of excess liver copper concentrations on response to a bovine respiratory disease challenge in lightweight beef-on-dairy crossbred steers. J Anim Sci.

[164] Ahmed, A. E., Nakai, M., Kakiya, M., et al. Histopathology of nasopharyngeal and palatine tonsils in Japanese black calves naturally infected with Mycoplasma bovis. J Vet Med Sci.

[165] Ohira, K., Yokoe, K., Li, K., et al. Seroprevalence of influenza C and D virus infections among cattle in Japan. Vet Anim Sci.

[166] Rubio, C. P., Rigueira, L., Miranda, M., et al. Validation of the Measurement of Beta-Hydroxybutyrate and Non-Esterified Fatty Acids in Bovine Saliva: A Pilot Report. Life (Basel).

[167] Ren, Y., Chen, X., Tang, C., et al. First isolation and characterization of a bovine parainfluenza virus type 3 genotype C strain from an aborted Holstein fetus. Front Vet Sci.

[168] Garzon, A., Miramontes, C., Weimer, B. C., et al. Comparison of virulence and resistance genes in Mannheimia haemolytica and Pasteurella multocida from dairy cattle with and without bovine respiratory disease. Microbiol Spectr.

[169] Mustonen, K., Härtel, H., Simojoki, H. Effect of vaccination against bovine respiratory disease (BRD) in a calf rearing unit in Finland. Acta Vet Scand.

[170] Heinen, L., Lancaster, P. A., Larson, R. L., et al. Predictive models to determine best strategy for metaphylaxis application in cattle at arrival to a feedyard. Prev Vet Med.

[171] Wynn, E., Dassanayake, R., Nielsen, D., et al. Diversity and T-cell antigenic potentials of Mycoplasma mycoides subsp. mycoides vaccine candidates. Genome.

[172] Küçük, A., Yildirim, Y., Çetintav, B. Assessment of Risk Factors Related to Environmental Factors and Herd Management for Bovine Respiratory Syncytial Virus and Bovine Parainfluenza Virus-3 Infections Frequently Observed in Beef and Dairy Cattle. Vet Med Sci.

[173] Rouault, M., Foucras, G., Meurens, F., et al. Thoracic Ultrasonography Findings and Their Association With Respiratory Pathogens in 221 Young Beef Cattle at Fattening Farms: A Cross-Sectional Study. J Vet Intern Med.

[174] Jiang, Q., Ma, Z., Min, F., et al. Screening of Bovine Coronavirus Multiepitope Vaccine Candidates: An Immunoinformatics Approach. Transbound Emerg Dis.

[175] Buttke, D. E., Schwartz, K., Schwalbe, E., et al. Mycoplasma bovis Outbreak and Maintenance of Subclinical Infections in An Exposed Cohort of Juvenile American Bison (Bison bison). J Wildl Dis.

[176] Sánchez-Fernández, A., Gardón, J. C., Ibáñez, C., et al. Use of Ultrasonography for the Evaluation of Lung Lesions in Lambs with Respiratory Complex. Animals (Basel).

[177] Demil, A., Dourcy, M., Garigliany, M. M., et al. Phylogenetic Analysis of Bovine Respiratory Syncytial Virus (BRSV) Subgroups in Wallonia Region of Belgium in Relation to Current Vaccination Strategies. Vaccines (Basel).

[178] Lebedev, M., Walsh, P., Newman, J. W., et al. Immune mechanisms affected by cyclooxygenase inhibition combined with antiviral treatment in calves infected with bovine respiratory syncytial virus. PLoS One.

[179] Monteiro, H. F., Hoyos-Jaramillo, A., Garzon, A., et al. Antibiogram use on dairy cattle for bovine respiratory disease: Factors associated with bacterial pathogen identification and prediction of bacterial recovery using machine learning. J Dairy Sci.

[180] Totton, S. C., Sargeant, J. M., O'Connor, A. M. Incomplete reporting in randomized controlled trials of bovine respiratory disease vaccines in feedlot cattle. Am J Vet Res.

[181] Sanguinetti, V. M., Strong, K., Agbese, S. P., et al. A systematic review of disease control strategies in beef cow-calf herds, part 2: preweaned calf morbidity and mortality associated with neonatal calf diarrhea and bovine respiratory disease. Anim Health Res Rev.

[182] Strillacci, M. G., Ferrulli, V., Bernini, F., et al. Genomic analysis of bovine respiratory disease resistance in preweaned dairy calves diagnosed by a combination of clinical signs and thoracic ultrasonography. PLoS One.

[183] Farahmand-Azar, S., Tukmechi, A., Ownagh, A. Genotyping and phylogenetic analysis of Mannheimia haemolytica isolates from cattle and buffaloes of West Azerbaijan, Iran. Vet Res Forum.